The indolent B-cell lymphomas. 2006

Peter McLaughlin
University of Texas M.D. Anderson Cancer Center, Department of Lymphoma/Myeloma, 1515 Holcombe Blvd., Box 429, Houston, TX 77030, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016032 Randomized Controlled Trials as Topic Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table. Clinical Trials, Randomized,Controlled Clinical Trials, Randomized,Trials, Randomized Clinical
D016393 Lymphoma, B-Cell A group of heterogeneous lymphoid tumors generally expressing one or more B-cell antigens or representing malignant transformations of B-lymphocytes. B-Cell Lymphoma,B Cell Lymphoma,B-Cell Lymphomas,Lymphoma, B Cell,Lymphomas, B-Cell

Related Publications

Peter McLaughlin
December 1997, Oncology (Williston Park, N.Y.),
Peter McLaughlin
August 2014, Clinical lymphoma, myeloma & leukemia,
Peter McLaughlin
May 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
Peter McLaughlin
January 2023, Frontiers in immunology,
Peter McLaughlin
January 2021, Journal of hematology & oncology,
Peter McLaughlin
June 2015, Hematological oncology,
Peter McLaughlin
January 2012, TheScientificWorldJournal,
Peter McLaughlin
August 2009, Hematology/oncology clinics of North America,
Peter McLaughlin
January 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Peter McLaughlin
May 2023, Pathologie (Heidelberg, Germany),
Copied contents to your clipboard!